IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $3.96, $0.24 better than the analyst estimate of $3.72. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.19 billion.

GUIDANCE:

IDEXX Labs sees FY2026 EPS of $14.96-$15.16, versus the consensus of $14.88. IDEXX Labs sees FY2026 revenue of $4.74-4.76 billion, versus the consensus of $4.72 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.